Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target

Journal of Hepatology

Volumn 55, Issue 4, 2011, Pages 920-932

  Dongiovanni, Paola ^a   Fracanzani, Anna Ludovica ^a   Fargion, Silvia ^a   Valenti, Luca ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Hereditary hemochromatosis; Insulin resistance; Iron; Metabolic syndrome; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Oxidative stress; Vascular damage

Indexed keywords

ADIPOCYTOKINE; ALPHA 1 ANTITRYPSIN; CARBOHYDRATE; FERRITIN; IRON; LEPTIN; LIVER ENZYME; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN;

ADIPOSE TISSUE; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CELL GROWTH; DISEASE ASSOCIATION; DISEASE COURSE; DNA DAMAGE; DRUG TARGETING; DYSMETABOLIC IRON OVERLOAD SYNDROME; FATTY LIVER; GENETICS; HEREDITY; HISTORY; HUMAN; HYPERFERRITINEMIA; INFLAMMATION; INSULIN RESISTANCE; IRON DEPLETION; IRON OVERLOAD; IRON THERAPY; IRON TRANSPORT; LIVER CELL; LIVER CELL CARCINOMA; LIVER INJURY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PHLEBOTOMY; PRIORITY JOURNAL; REVIEW; STEATOSIS; STELLATE CELL;

FATTY LIVER; HEMOCHROMATOSIS; HUMANS; IRON; METABOLIC SYNDROME X; OXIDATIVE STRESS; PREVALENCE; RISK FACTORS;

EID: 80052940689     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.05.008     Document Type: Review

References (153)

1. M. Jehn, J.M. Clark, and E. Guallar Serum ferritin and risk of the metabolic syndrome in US adults Diabetes Care 27 2004 2422 2428 (Pubitemid 39281396)
2. C. Bozzini, D. Girelli, O. Olivieri, N. Martinelli, A. Bassi, and G. De Matteis Prevalence of body iron excess in the metabolic syndrome Diabetes Care 28 2005 2061 2063 (Pubitemid 41060992)
3. C.E. Wrede, R. Buettner, L.C. Bollheimer, J. Scholmerich, K.D. Palitzsch, and C. Hellerbrand Association between serum ferritin and the insulin resistance syndrome in a representative population Eur J Endocrinol 154 2006 333 340
4. C.H. Kim, H.K. Kim, S.J. Bae, J.Y. Park, and K.U. Lee Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women Metabolism 60 2010 414 420
5. J.T. Salonen, T.P. Tuomainen, R. Salonen, T.A. Lakka, and K. Nyyssonen Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study Am J Epidemiol 148 1998 445 451 (Pubitemid 28411101)
6. E.S. Ford, and M.E. Cogswell Diabetes and serum ferritin concentration among US adults Diabetes Care 22 1999 1978 1983 (Pubitemid 30433975)
7. R. Jiang, J.E. Manson, J.B. Meigs, J. Ma, N. Rifai, and F.B. Hu Body iron stores in relation to risk of type 2 diabetes in apparently healthy women JAMA 291 2004 711 717 (Pubitemid 38543791)
8. N.G. Forouhi, A.H. Harding, M. Allison, M.S. Sandhu, A. Welch, and R. Luben Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study Diabetologia 50 2007 949 956 (Pubitemid 46559245)
9. R.T. Acton, J.C. Barton, L.V. Passmore, P.C. Adams, M.R. Speechley, and F.W. Dawkins Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study Diabetes Care 29 2006 2084 2089 (Pubitemid 44871191)
10. H.F. Escobar-Morreale, M. Luque-Ramirez, F. Alvarez-Blasco, J.I. Botella-Carretero, J. Sancho, and J.L. San Millan Body iron stores are increased in overweight and obese women with polycystic ovary syndrome Diabetes Care 28 2005 2042 2044 (Pubitemid 41060986)
11. D.A. Ehrmann Polycystic ovary syndrome N Engl J Med 352 2005 1223 1236
12. M. Luque-Ramirez, F. Alvarez-Blasco, J.I. Botella-Carretero, R. Sanchon, J.L. San Millan, and H.F. Escobar-Morreale Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses Diabetes Care 30 2007 2309 2313 (Pubitemid 47359039)
13. M.H. Mendler, B. Turlin, R. Moirand, A.M. Jouanolle, T. Sapey, and D. Guyader Insulin resistance-associated hepatic iron overload Gastroenterology 117 1999 1155 1163 (Pubitemid 29512675)
14. L. Valenti, P. Dongiovanni, A.L. Fracanzani, G. Santorelli, E. Fatta, and C. Bertelli Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis Dig Liver Dis 35 2003 172 178 (Pubitemid 40668461)
15. L. Valenti, A.L. Fracanzani, P. Dongiovanni, E. Bugianesi, G. Marchesini, and P. Manzini Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study Am J Gastroenterol 102 2007 1251 1258 (Pubitemid 46802029)
16. L. Valenti, P. Dongiovanni, A. Piperno, A.L. Fracanzani, M. Maggioni, and R. Rametta Alpha1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage Hepatology 44 2006 857 864 (Pubitemid 46489549)
17. L. Valenti, A.L. Fracanzani, E. Bugianesi, P. Dongiovanni, E. Galmozzi, and E. Vanni HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease Gastroenterology 138 2010 905 912
18. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, and P. Carucci Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140 (Pubitemid 34747534)
19. A.L. Fracanzani, L. Burdick, S. Raselli, P. Pedotti, L. Grigore, and G. Santorelli Carotid artery intima-media thickness in nonalcoholic fatty liver disease Am J Med 121 2008 72 78
20. J.D. Browning, L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, and J.C. Cohen Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395 (Pubitemid 39657013)
21. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, and M. Lenzi Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 2001 1844 1850 (Pubitemid 33641605)
22. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
23. G. Marchesini, E. Bugianesi, G. Forlani, F. Cerrelli, M. Lenzi, and R. Manini Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 2003 917 923 (Pubitemid 36397405)
24. N. Villanova, S. Moscatiello, S. Ramilli, E. Bugianesi, D. Magalotti, and E. Vanni Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease Hepatology 42 2005 473 480 (Pubitemid 41061101)
25. M. Ekstedt, L.E. Franzen, U.L. Mathiesen, L. Thorelius, M. Holmqvist, and G. Bodemar Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873 (Pubitemid 46489550)
26. C.P. Day From fat to inflammation Gastroenterology 130 2006 207 210 (Pubitemid 43049850)
27. B. Turlin, M.H. Mendler, R. Moirand, D. Guyader, A. Guillygomarc'h, and Y. Deugnier Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients Am J Clin Pathol 116 2001 263 270 (Pubitemid 33044332)
28. D. Barisani, S. Pelucchi, R. Mariani, S. Galimberti, P. Trombini, and D. Fumagalli Hepcidin and iron-related gene expression in subjects with dysmetabolic hepatic iron overload J Hepatol 49 2008 123 133
29. A. Riva, P. Trombini, R. Mariani, A. Salvioni, S. Coletti, and S. Bonfadini Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome World J Gastroenterol 14 2008 4745 4752
30. R. Moirand, M.H. Mendler, A. Guillygomarc'h, P. Brissot, and Y. Deugnier Non-alcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload? J Hepatol 33 2000 1024 1026
31. A. Pietrangelo Hereditary hemochromatosis - a new look at an old disease N Engl J Med 350 2004 2383 2397
32. J.E. Nelson, L. Wilson, E.M. Brunt, M.M. Yeh, D.E. Kleiner, and A. Unalp-Arida Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease Hepatology 53 2011 448 457
33. E. Nemeth, and T. Ganz Regulation of iron metabolism by hepcidin Annu Rev Nutr 26 2006 323 342
34. M. Ruivard, F. Laine, T. Ganz, G. Olbina, M. Westerman, and E. Nemeth Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin J Hepatol 50 2009 1219 1225
35. J.M. Fernandez-Real, W. Ricart-Engel, E. Arroyo, R. Balanca, R. Casamitjana-Abella, and D. Cabrero Serum ferritin as a component of the insulin resistance syndrome Diabetes Care 21 1998 62 68 (Pubitemid 28030387)
36. P.C. Adams, D.M. Reboussin, J.C. Barton, C.E. McLaren, J.H. Eckfeldt, and G.D. McLaren Hemochromatosis and iron-overload screening in a racially diverse population N Engl J Med 352 2005 1769 1778 (Pubitemid 40570925)
37. M. Haap, J. Machann, C. von Friedeburg, F. Schick, N. Stefan, and N.F. Schwenzer Insulin sensitivity and liver fat: role of iron load J Clin Endocrinol Metab 96 2011 E958 E961
38. L. Valenti, D.W. Swinkels, L. Burdick, P. Dongiovanni, H. Tjalsma, and B.M. Motta Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease Nutr Metab Cardiovasc Dis 31 2011 683 690
39. Manco M, Alisi A, Real JM, Equitani F, Devito R, Valenti L, et al. Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease. J Hepatol 2011. in press [PMID: 21168460.
40. E. Bugianesi, P. Manzini, S. D'Antico, E. Vanni, F. Longo, and N. Leone Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver Hepatology 39 2004 179 187 (Pubitemid 38461480)
41. L. Valenti, E. Canavesi, E. Galmozzi, P. Dongiovanni, R. Rametta, and P. Maggioni Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease J Hepatol 53 2010 927 933
42. S. Pelucchi, R. Mariani, A. Salvioni, S. Bonfadini, A. Riva, and F. Bertola Novel mutations of the ferroportin gene (SLC40A1): analysis of 56 consecutive patients with unexplained iron overload Clin Genet 73 2008 171 178
43. E. Aigner, I. Theurl, M. Theurl, D. Lederer, H. Haufe, and O. Dietze Pathways underlying iron accumulation in human nonalcoholic fatty liver disease Am J Clin Nutr 87 2008 1374 1383 (Pubitemid 351679780)
44. C. Pigeon, G. Ilyin, B. Courselaud, P. Leroyer, B. Turlin, and P. Brissot A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload J Biol Chem 276 2001 7811 7819
45. E. Aigner, I. Theurl, H. Haufe, M. Seifert, F. Hohla, and L. Scharinger Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease Gastroenterology 135 2008 680 688
46. A.J. Sanyal Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease Nat Clin Pract Gastroenterol Hepatol 2 2005 46 53 (Pubitemid 40812527)
47. J.R. Prohaska, J. Geissler, B. Brokate, and M. Broderius Copper, zinc-superoxide dismutase protein but not mRNA is lower in copper-deficient mice and mice lacking the copper chaperone for superoxide dismutase Exp Biol Med (Maywood) 228 2003 959 966 (Pubitemid 37163249)
48. Y. Nose, B.E. Kim, and D.J. Thiele Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function Cell Metab 4 2006 235 244 (Pubitemid 44283961)
49. Y. Wei, R.S. Rector, J.P. Thyfault, and J.A. Ibdah Nonalcoholic fatty liver disease and mitochondrial dysfunction World J Gastroenterol 14 2008 193 199 (Pubitemid 351314298)
50. E. Aigner, M. Strasser, H. Haufe, T. Sonnweber, F. Hohla, and A. Stadlmayr A role for low hepatic copper concentrations in nonalcoholic fatty liver disease Am J Gastroenterol 105 2010 1978 1985
51. K. Otogawa, K. Kinoshita, H. Fujii, M. Sakabe, R. Shiga, and K. Nakatani Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis Am J Pathol 170 2007 967 980 (Pubitemid 47339365)
52. L. Valenti, P. Dongiovanni, A.L. Fracanzani, and S. Fargion HFE mutations in nonalcoholic fatty liver disease Hepatology 47 2008 1794 1795 [author reply 1795-1796 (Pubitemid 351702767)
53. S. Chitturi, M. Weltman, G.C. Farrell, D. McDonald, J. Kench, and C. Liddle HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity Hepatology 36 2002 142 149 (Pubitemid 34700771)
54. S. Neri, D. Pulvirenti, S. Signorelli, L. Ignaccolo, A. Tsami, and B. Mauceri The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations Intern Med J 38 2008 254 258 (Pubitemid 351465442)
55. M.L. Eigenbrodt, T.M. McCashland, R.M. Dy, J. Clark, and J. Galati Heterozygous alpha 1-antitrypsin phenotypes in patients with end stage liver disease Am J Gastroenterol 92 1997 602 607 (Pubitemid 27184372)
56. L. Serfaty, O. Chazouilleres, A. Poujol-Robert, L. Morand-Joubert, C. Dubois, and Y. Chretien Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study Hepatology 26 1997 776 779 (Pubitemid 27392373)
57. I.W. Graziadei, J.J. Joseph, R.H. Wiesner, T.M. Therneau, K.P. Batts, and M.K. Porayko Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency Hepatology 28 1998 1058 1063 (Pubitemid 28450267)
58. C. Vecchi, G. Montosi, K. Zhang, I. Lamberti, S.A. Duncan, and R.J. Kaufman ER stress controls iron metabolism through induction of hepcidin Science 325 2009 877 880
59. S. Fargion, P. Dongiovanni, A. Guzzo, S. Colombo, L. Valenti, and A.L. Fracanzani Iron and insulin resistance Aliment Pharmacol Ther 22 2005 61 63 (Pubitemid 41564386)
60. R.C. Cooksey, H.A. Jouihan, R.S. Ajioka, M.W. Hazel, D.L. Jones, and J.P. Kushner Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis Endocrinology 145 2004 5305 5312 (Pubitemid 39551152)
61. R.C. Cooksey, D. Jones, S. Gabrielsen, J. Huang, J.A. Simcox, and B. Luo Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse Am J Physiol Endocrinol Metab 298 2010 E1236 E1243
62. J. Huang, D. Jones, B. Luo, M. Sanderson, J. Soto, and E.D. Abel Iron overload and diabetes risk: a shift from glucose to fatty acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis Diabetes 60 2010 80 87
63. Y. Minamiyama, S. Takemura, S. Kodai, H. Shinkawa, T. Tsukioka, and H. Ichikawa Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats Am J Physiol Endocrinol Metab 298 2010 E1140 E1149
64. J.M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart Cross-talk between iron metabolism and diabetes Diabetes 51 2002 2348 2354 (Pubitemid 34827381)
65. N. Houstis, E.D. Rosen, and E.S. Lander Reactive oxygen species have a causal role in multiple forms of insulin resistance Nature 440 2006 944 948
66. S. Furukawa, T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, and Y. Nakajima Increased oxidative stress in obesity and its impact on metabolic syndrome J Clin Invest 114 2004 1752 1761 (Pubitemid 40385531)
67. H. Urakawa, A. Katsuki, Y. Sumida, E.C. Gabazza, S. Murashima, and K. Morioka Oxidative stress is associated with adiposity and insulin resistance in men J Clin Endocrinol Metab 88 2003 4673 4676 (Pubitemid 37357510)
68. J. Lin, R. Yang, P.T. Tarr, P.H. Wu, C. Handschin, and S. Li Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP Cell 120 2005 261 273 (Pubitemid 40174768)
69. L. Valenti, D. Conte, A. Piperno, P. Dongiovanni, A.L. Fracanzani, and M. Fraquelli The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis J Med Genet 41 2004 946 950 (Pubitemid 40007257)
70. H.A. Jouihan, P.A. Cobine, R.C. Cooksey, E.A. Hoagland, S. Boudina, and E.D. Abel Iron-mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis Mol Med 14 2008 98 108 (Pubitemid 351481840)
71. A. Scaccabarozzi, P. Arosio, G. Weiss, L. Valenti, P. Dongiovanni, and A.L. Fracanzani Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells Br J Haematol 110 2000 978 984
72. S. Fargion, L. Valenti, P. Dongiovanni, A. Scaccabarozzi, A.L. Fracanzani, and E. Taioli Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis Blood 97 2001 3707 3712
73. H. She, S. Xiong, M. Lin, E. Zandi, C. Giulivi, and H. Tsukamoto Iron activates NF-κB in Kupffer cells Am J Physiol Gastrointest Liver Physiol 283 2002 G719 G726
74. L. Valenti, A.L. Fracanzani, P. Dongiovanni, G. Santorelli, A. Branchi, and E. Taioli Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease Gastroenterology 122 2002 274 280 (Pubitemid 34116980)
75. P.A. Kern, G.B. Di Gregorio, T. Lu, N. Rassouli, and G. Ranganathan Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression Diabetes 52 2003 1779 1785 (Pubitemid 36792470)
76. G.S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M.F. White, and B.M. Spiegelman IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance Science 271 1996 665 668 (Pubitemid 26052915)
77. A. Green, R. Basile, and J.M. Rumberger Transferrin and iron induce insulin resistance of glucose transport in adipocytes Metabolism 55 2006 1042 1045 (Pubitemid 44026544)
78. J. Huang, J.S. Gabrielsen, R.C. Cooksey, B. Luo, L.G. Boros, and D.L. Jones Increased glucose disposal and AMP-dependent kinase signaling in a mouse model of hemochromatosis J Biol Chem 282 2007 37501 37507
79. P. Ramos, E. Guy, N. Chen, C.C. Proenca, S. Gardenghi, and C. Casu Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis Blood 117 2011 1379 1389
80. P. Dongiovanni, M. Ruscica, L. Benedan, V. Borroni, S. Recalcati, and L. Steffani Dietary iron overload induces visceral adipose tissue insulin resistance associated with hyper-resistinemia, and synergizes with obesity and fatty liver in inducing systemic insulin resistance J Hepatol 54 2011 S505
81. G. Lutchman, A. Modi, D.E. Kleiner, K. Promrat, T. Heller, and M. Ghany The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis Hepatology 46 2007 424 429 (Pubitemid 47344777)
82. J.Y. Kim, E. van de Wall, M. Laplante, A. Azzara, M.E. Trujillo, and S.M. Hofmann Obesity-associated improvements in metabolic profile through expansion of adipose tissue J Clin Invest 117 2007 2621 2637 (Pubitemid 47494363)
83. G. Musso, R. Gambino, G. Biroli, M. Carello, E. Faga, and G. Pacini Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis Am J Gastroenterol 100 2005 2438 2446
84. S.A. Polyzos, K.A. Toulis, D.G. Goulis, C. Zavos, and J. Kountouras Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis Metabolism 60 2011 313 326
85. Y. Aso, K. Takebayashi, S. Wakabayashi, A. Momobayashi, N. Sugawara, and T. Terasawa Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes Diabetes Res Clin Pract 90 2010 250 255
86. B.J. Ku, S.Y. Kim, T.Y. Lee, and K.S. Park Serum ferritin is inversely correlated with serum adiponectin level: population-based cross-sectional study Dis Markers 27 2009 303 310
87. H. Lin, C.H. Yu, C.Y. Jen, C.F. Cheng, Y. Chou, and C.C. Chang Adiponectin-mediated heme oxygenase-1 induction protects against iron-induced liver injury via a PPAR{alpha}-dependent mechanism Am J Pathol 177 2010 1697 1709
88. F.P. Lee, C.Y. Jen, C.C. Chang, Y. Chou, H. Lin, and C.M. Chou Mechanisms of adiponectin-mediated COX-2 induction and protection against iron injury in mouse hepatocytes J Cell Physiol 224 2010 837 847
89. J.L. Halaas, C. Boozer, J. Blair-West, N. Fidahusein, D.A. Denton, and J.M. Friedman Physiological response to long-term peripheral and central leptin infusion in lean and obese mice Proc Natl Acad Sci USA 94 1997 8878 8883 (Pubitemid 27335133)
90. M. Maffei, J. Halaas, E. Ravussin, R.E. Pratley, G.H. Lee, and Y. Zhang Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects Nat Med 1 1995 1155 1161
91. J.M. Friedman, and J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 1998 763 770 (Pubitemid 28485436)
92. W. Huang, N. Dedousis, and R.M. O'Doherty Hepatic steatosis and plasma dyslipidemia induced by a high-sucrose diet are corrected by an acute leptin infusion J Appl Physiol 102 2007 2260 2265 (Pubitemid 47080758)
93. N.K. Saxena, D. Sharma, X. Ding, S. Lin, F. Marra, and D. Merlin Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells Cancer Res 67 2007 2497 2507 (Pubitemid 46548934)
94. M. Kitade, H. Yoshiji, H. Kojima, Y. Ikenaka, R. Noguchi, and K. Kaji Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats Hepatology 44 2006 983 991 (Pubitemid 46489563)
95. B. Chung, P. Matak, A.T. McKie, and P. Sharp Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells J Nutr 137 2007 2366 2370 (Pubitemid 350058702)
96. E.M. del Giudice, N. Santoro, A. Amato, C. Brienza, P. Calabro, and E.T. Wiegerinck Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency J Clin Endocrinol Metab 94 2009 5102 5107
97. C.M. Steppan, S.T. Bailey, S. Bhat, E.J. Brown, R.R. Banerjee, and C.M. Wright The hormone resistin links obesity to diabetes Nature 409 2001 307 312 (Pubitemid 32151228)
98. R. Palanivel, and G. Sweeney Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin FEBS Lett 579 2005 5049 5054 (Pubitemid 41242851)
99. C.M. Steppan, J. Wang, E.L. Whiteman, M.J. Birnbaum, and M.A. Lazar Activation of SOCS-3 by resistin Mol Cell Biol 25 2005 1569 1575 (Pubitemid 40204931)
100. S.R. Smith, F. Bai, C. Charbonneau, L. Janderova, and G. Argyropoulos A promoter genotype and oxidative stress potentially link resistin to human insulin resistance Diabetes 52 2003 1611 1618 (Pubitemid 36792447)
101. F. Felipe, M.L. Bonet, J. Ribot, and A. Palou Modulation of resistin expression by retinoic acid and vitamin A status Diabetes 53 2004 882 889 (Pubitemid 38436599)
102. S. Bo, G. Ciccone, M. Durazzo, R. Gambino, P. Massarenti, and I. Baldi Efficacy of antioxidant treatment in reducing resistin serum levels: a randomized study PLoS Clin Trials 2 2007 e17
103. A. Fukuhara, M. Matsuda, M. Nishizawa, K. Segawa, M. Tanaka, and K. Kishimoto Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426 430 (Pubitemid 40139988)
104. J.M. Fernandez-Real, J.M. Moreno, B. Chico, A. Lopez-Bermejo, and W. Ricart Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance Diabetes Care 30 2007 616 621 (Pubitemid 46354343)
105. J.M. Fernandez-Real, J.M. Moreno, and W. Ricart Circulating RBP4 concentration might reflect insulin resistance-associated iron overload Diabetes 57 2008 1918 1925
106. G. Targher, L. Bertolini, R. Padovani, S. Rodella, G. Zoppini, and L. Zenari Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease Diabetes Care 29 2006 1325 1330 (Pubitemid 44125930)
107. P. Jepsen, H. Vilstrup, L. Mellemkjaer, A.M. Thulstrup, J.H. Olsen, and J.A. Baron Prognosis of patients with a diagnosis of fatty liver - a registry-based cohort study Hepatogastroenterology 50 2003 2101 2104 (Pubitemid 37468003)
108. D. Lapenna, S.D. Pierdomenico, G. Ciofani, S. Ucchino, M. Neri, and M.A. Giamberardino Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques Free Radic Biol Med 42 2007 492 498 (Pubitemid 46162117)
109. A.D. van der, P.H. Peeters, D.E. Grobbee, M. Roest, J.J. Marx, and H.M. Voorbij HFE mutations and risk of coronary heart disease in middle-aged women Eur J Clin Invest 36 2006 682 690 (Pubitemid 44393926)
110. M.C. Pardo Silva, O.T. Njajou, B.Z. Alizadeh, A. Hofman, J.C. Witteman, and C.M. van Duijn HFE gene mutations increase the risk of coronary heart disease in women Eur J Epidemiol 25 2010 643 649
111. J. Danesh, and P. Appleby Coronary heart disease and iron status: meta-analyses of prospective studies Circulation 99 1999 852 854 (Pubitemid 29094295)
112. J.L. Sullivan Macrophage iron, hepcidin, and atherosclerotic plaque stability Exp Biol Med (Maywood) 232 2007 1014 1020 (Pubitemid 47358184)
113. T. Ganz, and E. Nemeth Iron imports. IV. Hepcidin and regulation of body iron metabolism Am J Physiol Gastrointest Liver Physiol 290 2006 G199 G203
114. T.S. Lee, M.S. Shiao, C.C. Pan, and L.Y. Chau Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice Circulation 99 1999 1222 1229
115. L.R. Zacharski, B.K. Chow, P.S. Howes, G. Shamayeva, J.A. Baron, and R.L. Dalman Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial JAMA 297 2007 603 610
116. Y.H. Chen, L.Y. Chau, J.W. Chen, and S.J. Lin Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients Diabetes Care 31 2008 1615 1620
117. I. Theurl, M. Theurl, M. Seifert, S. Mair, M. Nairz, and H. Rumpold Autocrine formation of hepcidin induces iron retention in human monocytes Blood 111 2008 2392 2399 (Pubitemid 351451452)
118. P.C. Adams, J.S. Pankow, J.C. Barton, R.T. Acton, C. Leiendecker-Foster, and G.D. McLaren HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: the hemochromatosis and iron overload screening study Circ Cardiovasc Genet 2 2009 34 37
119. J.S. Pankow, E. Boerwinkle, P.C. Adams, E. Guallar, C. Leiendecker-Foster, and J. Rogowski HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study Transl Res 152 2008 3 10
120. T.M. Teslovich, K. Musunuru, A.V. Smith, A.C. Edmondson, I.M. Stylianou, and M. Koseki Biological, clinical and population relevance of 95 loci for blood lipids Nature 466 2010 707 713
121. L. Deiana, R. Garuti, G.M. Pes, C. Carru, A. Errigo, and M. Rolleri Influence of beta(0)-thalassemia on the phenotypic expression of heterozygous familial hypercholesterolemia: a study of patients with familial hypercholesterolemia from Sardinia Arterioscler Thromb Vasc Biol 20 2000 236 243 (Pubitemid 30048370)
122. M. Maioli, G.B. Vigna, G. Tonolo, P. Brizzi, M. Ciccarese, and P. Donega Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in beta-thalassemia Atherosclerosis 131 1997 127 133 (Pubitemid 27240105)
123. L. Valenti, P. Dongiovanni, B.M. Motta, D.W. Swinkels, P. Bonara, and R. Rametta Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations Arterioscler Thromb Vasc Biol 31 2011 683 690
124. P. Sorrentino, S. D'Angelo, U. Ferbo, P. Micheli, A. Bracigliano, and R. Vecchione Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis J Hepatol 50 2009 351 357
125. J.E. Nelson, R. Bhattacharya, K.D. Lindor, N. Chalasani, S. Raaka, and E.J. Heathcote HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis Hepatology 46 2007 723 729 (Pubitemid 47436118)
126. K.S. Lee, M. Buck, K. Houglum, and M. Chojkier Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression J Clin Invest 96 1995 2461 2468
127. F. Marra, and C. Bertolani Adipokines in liver diseases Hepatology 50 2009 957 969
128. Y. Sumida, T. Yoshikawa, and T. Okanoue Role of hepatic iron in non-alcoholic steatohepatitis Hepatol Res 39 2009 213 222
129. C.P. Day Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842 845
130. A.J. Sanyal, N. Chalasani, K.V. Kowdley, A. McCullough, A.M. Diehl, and N.M. Bass Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 362 2010 1675 1685
131. K. Otogawa, T. Ogawa, R. Shiga, K. Nakatani, K. Ikeda, and Y. Nakajima Attenuation of acute and chronic liver injury in rats by iron-deficient diet Am J Physiol Regul Integr Comp Physiol 294 2008 R311 R320
132. N. Fujita, H. Miyachi, H. Tanaka, M. Takeo, N. Nakagawa, and Y. Kobayashi Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis Cancer Epidemiol Biomarkers Prev 18 2009 424 432
133. R.G. Ruddell, D. Hoang-Le, J.M. Barwood, P.S. Rutherford, T.J. Piva, and D.J. Watters Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells Hepatology 49 2009 887 900
134. K.E. Brown, P.A. Dennery, L.A. Ridnour, C.J. Fimmel, R.D. Kladney, and E.M. Brunt Effect of iron overload and dietary fat on indices of oxidative stress and hepatic fibrogenesis in rats Liver Int 23 2003 232 242 (Pubitemid 37265798)
135. E.E. Powell, A. Ali, A.D. Clouston, J.L. Dixon, D.J. Lincoln, and D.M. Purdie Steatosis is a cofactor in liver injury in hemochromatosis Gastroenterology 129 2005 1937 1943 (Pubitemid 41772971)
136. R. Kirsch, H.P. Sijtsema, M. Tlali, A.D. Marais, and L. Hall Pde Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease Liver Int 26 2006 1258 1267 (Pubitemid 44741214)
137. N. Imeryuz, V. Tahan, A. Sonsuz, F. Eren, S. Uraz, and M. Yuksel Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death J Hepatol 47 2007 851 859 (Pubitemid 350051114)
138. T. Takehara, T. Tatsumi, T. Suzuki, E.B. Rucker 3rd, L. Hennighausen, and M. Jinushi Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses Gastroenterology 127 2004 1189 1197 (Pubitemid 39345887)
139. A.E. Feldstein, A. Canbay, P. Angulo, M. Taniai, L.J. Burgart, and K.D. Lindor Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis Gastroenterology 125 2003 437 443 (Pubitemid 36929425)
140. S. Fargion, L. Valenti, and A.L. Fracanzani Hemochromatosis gene (HFE) mutations and cancer risk: expanding the clinical manifestations of hereditary iron overload Hepatology 51 2010 1119 1121
141. P. Dongiovanni, A. Fracanzani, G. Cairo, C.P. Megazzini, S. Gatti, and R. Rametta Iron dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis Am J Pathol 176 2010 10.2353/amjpath.2010.090249
142. P. Dongiovanni, L. Valenti, A. Ludovica Fracanzani, S. Gatti, G. Cairo, and S. Fargion Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver Am J Pathol 172 2008 738 747 (Pubitemid 351354546)
143. R. Potashnik, N. Kozlovsky, S. Ben-Ezra, A. Rudich, and N. Bashan Regulation of glucose transport and GLUT-1 expression by iron chelators in muscle cells in culture Am J Physiol 269 1995 E1052 E1058
144. M.J. Borel, J.L. Beard, and P.A. Farrell Hepatic glucose production and insulin sensitivity and responsiveness in iron-deficient anemic rats Am J Physiol 264 1993 E380 E390
145. A. Guillygomarc'h, M.H. Mendler, R. Moirand, F. Laine, V. Quentin, and V. David Venesection therapy of insulin resistance-associated hepatic iron overload J Hepatol 35 2001 344 349 (Pubitemid 32844188)
146. F.S. Facchini, N.W. Hua, and R.A. Stoohs Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease Gastroenterology 122 2002 931 939 (Pubitemid 34267276)
147. L. Valenti, A.L. Fracanzani, and S. Fargion Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance Gastroenterology 124 2003 866 [author reply 866-867
148. J.M. Fernandez-Real, G. Penarroja, A. Castro, F. Garcia-Bragado, I. Hernandez-Aguado, and W. Ricart Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function Diabetes 51 2002 1000 1004 (Pubitemid 34438342)
149. F. Equitani, J.M. Fernandez-Real, G. Menichella, M. Koch, Menotti Calvani, and V. Nobili Blood letting ameliorates insulin sensitivity and secretion in parallel to reduce iron overload in carriers of HFE mutations Diabetes Care 31 2008 3 8
150. J.M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart Iron stores, blood donation, and insulin sensitivity and secretion Clin Chem 51 2005 1201 1205 (Pubitemid 43079398)
151. A. Piperno, A. Vergani, A. Salvioni, P. Trombini, M. Vigano, and A. Riva Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome Liver Int 24 2004 471 476 (Pubitemid 40484562)
152. L. Valenti, S. Moscatiello, E. Vanni, A.L. Fracanzani, E. Bugianesi, and S. Fargion Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling - a propensity score-adjusted observational study QJM 104 2011 141 149
153. L.R. Zacharski, B.K. Chow, P.S. Howes, G. Shamayeva, J.A. Baron, and R.L. Dalman Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial J Natl Cancer Inst 100 2008 996 1002 (Pubitemid 352019800)